It seems that we all can agree that if you’re not feeling well, you should stay home from work. If…
Home »
SNRI ‘Shows Promise’ for Comorbid ADHD, PTSD
Atomoxetine, a selective norepinephrine reuptake inhibitor (SNRI), may improve outcomes for patients with both attention-deficit/hyperactivity disorder (ADHD) and posttraumatic stress…
Research in metaphors enables better understanding of depression and patients’ needs
“You have to win the battle against depression,” “what counts is not surrendering” and “this is not a short road”…
APO-Pregabalin
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-PREGABALIN Contains the active ingredient pregabalin Consumer…
Andepra
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ANDEPRA® Duloxetine hydrochloride Consumer Medicine Information What…
Dosulepin Mylan
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DOSULEPIN MYLAN contains the active ingredient dosulepin…
Tivicay
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TIVICAY 10 mg, 25 mg and 50…
Chemmart Venlafaxine XR
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CHEMMART VENLAFAXINE XR CAPSULES Contains the active…
Sevredol
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SEVREDOL® TABLETS Consumer Medicine Information (CMI)…
Trifeme
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TRIFEME® Levonorgestrel and Ethinylestradiol Tablets Consumer Medicine…